Kindred Ventures led the healthcare services provider's series E round, valuing it at $4.6bn.
Color, a US-based healthcare provider which draws on research from University of California, San Francisco and University of Pennsylvania, has secured $100m in a series E round more than tripling its valuation to $4.6bn.
Venture capital firm Kindred Ventures led the round, which also featured T Rowe Price, General Catalyst, Emerson Collective and Viking Global Investors. The transaction brings the company’s total funding to $378m.
Founded in 2015 as Color Genomics, Color provides healthcare services for employers, governments and school…
Fernando Moncada Rivera
Fernando Moncada Rivera is a reporter at Global Corporate Venturing and also host of the CVC Unplugged podcast.
